Minimal impact on the resistome of children in Botswana after azithromycin treatment for acute severe diarrhoeal disease
暂无分享,去创建一个
A. McArthur | Gerard D. Wright | M. Mokomane | K. Lechiile | D. Goldfarb | J. Pernica | Allison K. Guitor | Anna Katyukhina
[1] D. Operario,et al. Azithromycin for bacterial watery diarrhea: A reanalysis of the AntiBiotics for Children with severe Diarrhea (ABCD) trial incorporating molecular diagnostics. , 2023, The Journal of infectious diseases.
[2] Danny W. Wilson,et al. Targeting malaria parasites with novel derivatives of azithromycin , 2022, Frontiers in Cellular and Infection Microbiology.
[3] Damion M. Dooley,et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database , 2022, Nucleic Acids Res..
[4] G. Kang,et al. Frequency of bystander exposure to antibiotics for enteropathogenic bacteria among young children in low-resource settings , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[5] Amogelang R. Raphenya,et al. Capturing the antibiotic resistome of preterm infants reveals new benefits of probiotic supplementation , 2022, Microbiome.
[6] Joycelyne E Ewusie,et al. Optimising the management of childhood acute diarrhoeal disease using a rapid test-and- treat strategy and/or Lactobacillus reuteri DSM 17938: a multicentre, randomised, controlled, factorial trial in Botswana , 2022, BMJ Global Health.
[7] Hao Chung The,et al. Dynamic of the human gut microbiome under infectious diarrhea , 2022, Current opinion in microbiology.
[8] Alan D. Lopez,et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.
[9] C. Sudfeld,et al. Effect of 3 Days of Oral Azithromycin on Young Children With Acute Diarrhea in Low-Resource Settings , 2021, JAMA network open.
[10] Q. Bassat,et al. Pathogens Associated With Linear Growth Faltering in Children With Diarrhea and Impact of Antibiotic Treatment: The Global Enteric Multicenter Study , 2021, The Journal of infectious diseases.
[11] T. Mizutani,et al. Gut microbiota signature of pathogen-dependent dysbiosis in viral gastroenteritis , 2021, Scientific Reports.
[12] L. Worden,et al. Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] M. Lipsitch,et al. Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial , 2020, The New England journal of medicine.
[14] Eun Sug Park,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[15] J. Stearns,et al. Persistence of Suspected Probiotic Organisms in Preterm Infant Gut Microbiota Weeks After Probiotic Supplementation in the NICU , 2020, Frontiers in Microbiology.
[16] R. Haque,et al. Effect of Water, Sanitation, Handwashing, and Nutrition Interventions on Enteropathogens in Children 14 Months Old: A Cluster-Randomized Controlled Trial in Rural Bangladesh , 2020, The Journal of infectious diseases.
[17] Y. Hooda,et al. Mass azithromycin administration: considerations in an increasingly resistant world , 2020, BMJ Global Health.
[18] Chaojie Yang,et al. A new plasmid carrying mphA causes prevalence of azithromycin resistance in enterotoxigenic Escherichia coli serogroup O6 , 2020, BMC Microbiology.
[19] Amogelang R. Raphenya,et al. Capturing the Resistome: a Targeted Capture Method To Reveal Antibiotic Resistance Determinants in Metagenomes , 2019, Antimicrobial Agents and Chemotherapy.
[20] E. Chow,et al. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution , 2019, Nature Medicine.
[21] B. Godman,et al. Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications , 2019, Expert review of anti-infective therapy.
[22] T. Doan,et al. Macrolide Resistance in MORDOR I: A Cluster-Randomized Trial in Niger , 2019, The New England journal of medicine.
[23] K. Tapela,et al. Isolation and antibiotic resistance profiles of bacteria from influent, effluent and downstream: A study in Botswana , 2019, African Journal of Microbiology Research.
[24] E. Mworozi,et al. Barriers to effective uptake and provision of immunization in a rural district in Uganda , 2019, PloS one.
[25] D. Jannat-Khah,et al. Azithromycin and Childhood Mortality in Africa. , 2018, New England Journal of Medicine.
[26] Mark A. Miller,et al. Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study , 2018, The Lancet. Global health.
[27] Holly N. Dentz,et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Kenya: a cluster-randomised controlled trial , 2018, The Lancet. Global health.
[28] T. Clasen,et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on diarrhoea and child growth in rural Bangladesh: a cluster randomised controlled trial , 2018, The Lancet. Global health.
[29] M. Loeb,et al. Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial , 2017, PloS one.
[30] Mika Shigematsu,et al. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.
[31] C. Gomes,et al. Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin , 2016, Critical reviews in microbiology.
[32] W. van Schaik. The human gut resistome , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.
[33] Lawrence A. David,et al. Gut Microbial Succession Follows Acute Secretory Diarrhea in Humans , 2015, mBio.
[34] Carla J. Davidson,et al. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age , 2015, The ISME Journal.
[35] G. Verleden,et al. Azithromycin: mechanisms of action and their relevance for clinical applications. , 2014, Pharmacology & therapeutics.
[36] Mihai Pop,et al. Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition , 2014, Genome Biology.
[37] J. Kuehl,et al. The Gut as Reservoir of Antibiotic Resistance: Microbial Diversity of Tetracycline Resistance in Mother and Infant , 2011, PloS one.
[38] D. Relman,et al. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.
[39] C. Dolea,et al. World Health Organization , 1949, International Organization.
[40] P. J. Hooper,et al. Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review. , 2019, The Lancet. Infectious diseases.
[41] I. Kasvosve,et al. The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management , 2018, Therapeutic advances in infectious disease.